|
CSPS - The 5th Annual
Symposium, June 13-15,
Banff, Alberta
Assessing the plasma
pharmacokinetics, tissue
distribution, excretion and
effects on cholesterol
pharmacokinetics of a novel
hydrophilic compound,
FM-VP4, following
administration to rats.
Inhibition of human CYP3A4
activity by grapefruit
flavonoids, furanacoumarins
and related compounds.
Assessing plasma lipid
levels, body weight, and
hepatic and renal toxicity
following chronic oral
administration of a water
soluble phytostanol
compound, FM-VP4, to
gerbils.
Guar gum as a carrier for
colon specific delivery;
influence of metronidazole
and tinidazole on in vitro
release of albendazole from
guar gum matrix tablets.
High performance liquid
chromatography of
mebudipine: application to
pharmacokinetic study.
Novel therapeutic approaches
for uveitis and
retinitis.
Pharmacologic interventions
in nuclear medicine
assessment of cardiac
perfusion.
High-performance liquid
chromatographic assay of
amiodarone in rat plasma.
|
